Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2

American Journal of Ophthalmology

Volumn 131, Issue 5, 2001, Pages 541-560

  Arnold, J ^a   Barbezetto, I ^a   Birngruber, R ^a   Bressler, N M ^a   Bressler, S B ^a   Donati, G ^a   Fish, G E ^a   Flaxel, C J ^a   Gragoudas, E S ^a   Harvey, P ^a   Kaiser, P K ^a   Koester, J M ^a   Lewis, H ^a   Lim, J I ^a   Ma, C ^a   Meredith, T A ^a   Miller, J W ^a   Mones, J ^a   Murphy, S A ^a   Pieramici, D J ^a   Potter, M J ^a   Reaves, A ^a   Rosenfeld, P J ^a   Schachat, A P ^a   Schmidt Erfurth, U ^a   Singerman, L ^a   Strong, H A ^a   Stur, M ^a   Williams, G A ^a   more..

^a EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; SAFETY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; BLINDNESS; CHOROIDAL NEOVASCULARIZATION; DOUBLE-BLIND METHOD; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INFUSIONS, INTRAVENOUS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0035009086     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)00967-9     Document Type: Article

References (9)

1. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration; results of a single treatment in a phase 1 and 2 study
2. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration; results of a retreatments in a phase 1 and 2 study
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin; one-year results of 2 randomized clinical trials-TAP Report 1
4. Subfoveal neovascular lesions in age-related macular degeneration; guidelines for evaluation and treatment in the Macular Photocoagulation Study
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin; two-year results of 2 randomized clinical trials-TAP Report #2
6. Macular degeneration; do conventional measurements of impaired visual function equate with visual disability?